Comparing two pain medicines for sickle cell crisis in the emergency room
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study compares two pain medicines (parecoxib and morphine) given to people with sickle cell disease who come to the emergency room with a painful crisis. It aims to see which medicine works better and is safer for easing the pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have sickle cell disease.
- You are coming to the emergency room with moderate to severe pain from a sickle cell crisis (a vaso-occlusive crisis).
- Your pain is not caused by another problem like a lung issue, an infection, or a joint problem.
- You weigh at least 110 pounds (50 kilograms).
- You have not taken strong pain medicine (opioids) or anti-inflammatory pain medicine (like ibuprofen) in the last 24 hours.
- You are not pregnant, not breastfeeding, and do not have any allergies or medical conditions that prevent you from taking NSAIDs (like asthma or kidney disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This trial studies an approach to improve care during emergency room visits for uncomplicated sickle cell pain crises. It may help by guiding how pain is treated in the ER and tracking outcomes for people with sickle cell disease.
This trial tests whether a numbing medicine (lidocaine) given through a vein can help reduce the amount of strong painkillers (morphine or oxycodone) needed for a sickle cell pain crisis or acute chest syndrome. It aims to ease pain and possibly lower side effects from opioids.
This study tests whether a low dose of ketamine, a pain medicine, can safely reduce pain during a sickle cell crisis in the emergency department. It aims to provide quicker pain relief for people with sickle cell disease.
This trial tests whether numbing a specific area (regional anesthesia) can reduce inflammation and pain during a sickle cell pain crisis. It may offer a new way to manage severe pain without strong medications.
This trial tests a special painkiller called sufentanil given as a nasal spray to children with sickle cell disease who are having a severe pain crisis. It aims to see if this nasal spray works better or as well as usual pain treatment to quickly reduce pain in the emergency room.
Hear when a new Sickle-Cell Disease with Crisis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.